Tuesday, February 7, 2012

News Feed Comments

Forest Labs, Gedeon Richter announce phase II study results of cariprazine for bipolar depression

September 1, 2010 by Holistic Options
Filed under Holistic Recovery Options

Leave a Comment

Forest Laboratories, Inc. and Gedeon Richter Plc. announced preliminary top-line results from an 8-week phase II clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of bipolar depression.

Tags: bipolar disorder, depression, drug recovery

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!